Healthcare start-ups can be smart and agile, but even cutting-edge innovations can fail without clinical context. The iHub's 2014 Pilot Shark Tank brought Twine Health into Brigham and Women's Hospital last year, enabling exactly this type of (necessary) clinical validation. Read about Twine Health's major milestone earlier this month, closing their $6.7M Series A round:

The institutional investors that participated in the Series A round included Khosla Ventures, Provenance Venture Forum, and Tower Capital Partners. Other round participants were Andy Palmer, James Pallotta and retired Genzyme CEO Henri Termeer.